Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
24 June 2014Website:
http://benitec.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Mon, 01 Jul 2024 20:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
BNTC Latest News
HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced that Jerel A.
What type of business is Benitec Biopharma?
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
What sector is Benitec Biopharma in?
Benitec Biopharma is in the Healthcare sector
What industry is Benitec Biopharma in?
Benitec Biopharma is in the Biotechnology industry
What country is Benitec Biopharma from?
Benitec Biopharma is headquartered in United States
When did Benitec Biopharma go public?
Benitec Biopharma initial public offering (IPO) was on 24 June 2014
What is Benitec Biopharma website?
https://benitec.com
Is Benitec Biopharma in the S&P 500?
No, Benitec Biopharma is not included in the S&P 500 index
Is Benitec Biopharma in the NASDAQ 100?
No, Benitec Biopharma is not included in the NASDAQ 100 index
Is Benitec Biopharma in the Dow Jones?
No, Benitec Biopharma is not included in the Dow Jones index
When does Benitec Biopharma report earnings?
The next expected earnings date for Benitec Biopharma is 30 August 2024